Overview
|
Technical details
The token contract was developed using SmartPy and the code is available onto our github (github.com/covir-io). You can also read the full specifications onto our github page (readme.md). The contract was beforehand extensively tested onto babylonnet and carthagenet.
What is Covir
Covir is a platform that is designed to fund biosafety projects and licenses using blockchain technology. Biosafety licenses funded by Covir are for Octopus robots products; Octopus robots design biosafety equipment that decontaminates large buildings such as shopping malls, airport terminals, and food processing plants. Without a doubt, Covir project is the best blockchain project to invest in because biosafety projects are currently underrepresented in the blockchain world, despite there being a lot of opportunities in the biosafety industry. The current ravaging COVID-19 pandemic has accelerated the need for biosafety equipment.
DetailsPre-sales: Mar 01, 2020 - Aug 01, 2020Public sales: Aug 01, 2020 - Sep 01, 2020 IEO (Bitforex Launchpad): Jul 31, 2020 - Aug 25, 2020 Token supply: 400,000,000 CVR Soft cap: 500,000 USD Hard cap: 24,000,000 USD Raised: 160,000 USD LegalBlockchain Platform: TezosRegistration year: 2017 Office address: Rue Ancienne 88, 1215 Carouge GENEVE | Token infoTicker: CVRType: Utility-token Token standard: FA 1.2 Token price in USD: 1 CVR = 0,20 USD Accepted currencies: BTC, ETH, TRX, XTZ, USD Token distribution: 75% – Octopus Robots 10% – Operational costs 10% – Team & Advisors 5% – Reserve / Security Fund |
Covir Roadmap
Foundation of the company. It was named MCAI until April 2017. Initially, the company was specializing in developing and manufacturing metrology products for industrial applications.
The company was taken over by Mr. Olivier Somville who brought a new dynamic and opened up new markets .
MCAI took every opportunities and moved into various sectors such as HealthCare by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces.
MCAI has decided to massively invest in the development of innovative robots and hired a team of specialists. Since then, the company is exclusively devoted to develop its range of Octopus robots.
In 2012, our Company moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) for surfaces. It developed an innovative airborne disinfection system and sold it through a network of distributors worldwide.
In 2014, we moved into robotics completely. The “Octopus program” came alive.
The company was awarded the INNOV’SPACE’s Trophy for its Octopus Poultry Safe robot. Since June 2017 MCAI SAS becomes OCTOPUS ROBOTS SA.
Covir powered by www.octopusrobots.com for the financing of international licenses for robotic disinfection systems based on the Tezos blockchain.
As Covir continues to expand, we planned to publish various additional information regarding to operation of Covir (Royalties System, Tezos, multilingual)
Publication and availability of our wallet software for general public With different options. (Alpha version)
We will continue our development with the launch of the CVR pre-sale etc...
At the end of the third quarter, our investors will receive their first royalties. Distributions of Profits
Major announcement for COVIR, with the launch of the IEO on a reputable exchange.
Our token will then be listed at the end of our IEO, on the same exchange.